U.S. markets closed

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.84+0.12 (+0.37%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
Operating Expense
21,528
21,528
4,323
2,079
Operating Income
-21,528
-21,528
-4,323
-2,079
Net Non Operating Interest Income Expense
-593
-593
7
-24
Other Income Expense
-
-
-
-94
Pretax Income
-22,121
-22,121
-4,316
-2,197
Net Income Common Stockholders
-23,990
-23,990
-4,316
-2,197
Diluted NI Available to Com Stockholders
-23,990
-23,990
-4,316
-2,197
Basic EPS
-
-
-0.60
-0.16
Diluted EPS
-
-
-0.60
-0.16
Basic Average Shares
-
-
7,222
14,099
Diluted Average Shares
-
-
7,222
14,099
Total Operating Income as Reported
-21,528
-21,528
-4,323
-2,079
Total Expenses
21,528
21,528
4,323
2,079
Net Income from Continuing & Discontinued Operation
-22,121
-22,121
-4,316
-2,197
Normalized Income
-22,121
-22,121
-4,316
-2,103
Interest Income
60
60
7
4
Interest Expense
653
653
0
28
Net Interest Income
-593
-593
7
-24
EBIT
-21,468
-21,468
-4,316
-2,169
EBITDA
-21,457
-
-
-
Reconciled Depreciation
11
11
9
8
Net Income from Continuing Operation Net Minority Interest
-22,121
-22,121
-4,316
-2,197
Total Unusual Items Excluding Goodwill
0
0
0
-94
Total Unusual Items
0
0
0
-94
Normalized EBITDA
-21,457
-21,457
-4,307
-2,067
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0